Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2720]

Comment: Fulvestrant improves survival over anastrozole for patients with...

Prof Kent Osborne - Baylor College of Medicine, Houston, USA

Comment: Fulvestrant improves survival over anastrozole for patients with advanced breast cancer ( Prof Kent Osborne - Baylor College of Medicine, Houston, USA )

Comment: Multigene test can predict risk of disease recurrence for women with...

Prof Kent Osborne - Baylor College of Medicine, Houston, USA

Comment: Multigene test can predict risk of disease recurrence for women with ductal carcinoma in situ ( Prof Kent Osborne - Baylor College of Medicine, Houston, USA )

Comment: BOLERO-1 reports HER2-positive breast cancer latest PFS data

Prof Kent Osborne - Baylor College of Medicine, Houston, USA

Comment: BOLERO-1 reports HER2-positive breast cancer latest PFS data ( Prof Kent Osborne - Baylor College of Medicine, Houston, USA )

New IMRT techniques could be tissue-sparing and promote dosage conformity in...

Prof Lorenzo Livi - Careggi Hospital, Florence, Italy

New IMRT techniques could be tissue-sparing and promote dosage conformity in breast cancer ( Prof Lorenzo Livi - Careggi Hospital, Florence, Italy )

Tamoxifen lowered breast cancer rates among high-risk women

Prof Jack Cuzick - Wolfson Institute of Preventive Medicine, London, UK

Tamoxifen lowered breast cancer rates among high-risk women ( Prof Jack Cuzick - Wolfson Institute of Preventive Medicine, London, UK )

Fulvestrant versus anastrozole in patients with advanced breast cancer

Prof John Robertson - Royal Derby Hospital, Derby, UK

Fulvestrant versus anastrozole in patients with advanced breast cancer ( Prof John Robertson - Royal Derby Hospital, Derby, UK )

Reducing fat intake reduces death rates in some breast cancer patients

Professor Rowan Chlebowski - Harbor-UCLA Medical Centre, Torrance, USA

Reducing fat intake reduces death rates in some breast cancer patients ( Professor Rowan Chlebowski - Harbor-UCLA Medical Centre, Torrance, USA )

Recurrence risk could be predicted by a multigene test in ductal carcinoma...

Prof Eileen Rakovitch - Sunnybrook Research Institute, Toronto, Canada

Recurrence risk could be predicted by a multigene test in ductal carcinoma breast cancer ( Prof Eileen Rakovitch - Sunnybrook Research Institute, Toronto, Canada )

Breast cancer in men and women has different biological characteristics and...

Dr Fatima Cardoso - Champalimaud Cancer Center, Lisbon, Portugal

Breast cancer in men and women has different biological characteristics and outcomes ( Dr Fatima Cardoso - Champalimaud Cancer Center, Lisbon, Portugal )

PD-1 inhibitor pembrolizumab shows promising clinical activity for triple...

Dr Rita Nanda - University of Chicago Medicine, Chicago, USA

PD-1 inhibitor pembrolizumab shows promising clinical activity for triple-negative breast cancer ( Dr Rita Nanda - University of Chicago Medicine, Chicago, USA )

Comment: Impact of combined bevacizumab and presurgery chemo varies by subtype

Prof Carlos Arteaga - Vanderbilt-Ingram Cancer Center, Nashville, USA

Comment: Impact of combined bevacizumab and presurgery chemo varies by subtype ( Prof Carlos Arteaga - Vanderbilt-Ingram Cancer Center, Nashville, USA )

Adding ultrasound to routine mammography improves cancer detection in dense...

Dr Jean Weigert - Cancer Center of Central Connecticut, New Britain, USA

Adding ultrasound to routine mammography improves cancer detection in dense breasts ( Dr Jean Weigert - Cancer Center of Central Connecticut, New Britain, USA )

More from ecancer